Steroid responsive encephalopathy associated with autoimmune thyroiditis following ipilimumab therapy: a case report
Open Access
- 26 July 2015
- journal article
- case report
- Published by Springer Science and Business Media LLC in BMC Research Notes
- Vol. 8 (1), 316
- https://doi.org/10.1186/s13104-015-1283-9
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Neurological immune-related adverse events of ipilimumabPractical Neurology, 2013
- Prostate cancer may trigger paraneoplastic limbic encephalitis: A case report and a review of the literatureInternational Journal of Urology, 2012
- Characteristics and management of immune-related adverse effects associated with ipilimumab, a new immunotherapy for metastatic melanomaCancer Management and Research, 2012
- Management of Immune-Related Adverse Events and Kinetics of Response With IpilimumabJournal of Clinical Oncology, 2012
- Paraneoplastic neurological and hematological syndromes associated with prostate cancerInternational Journal of Urology, 2012
- Drug-Induced Graves Disease From CTLA-4 Receptor SuppressionOphthalmic Plastic & Reconstructive Surgery, 2011
- Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapyActa Endocrinologica, 2011
- Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic AdenocarcinomaJournal of Immunotherapy, 2010
- Hashimoto's EncephalopathyAnnals of the New York Academy of Sciences, 2008
- Serum TSH, T4, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)Journal of Clinical Endocrinology & Metabolism, 2002